VNRX-5133

· Venatorx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VNRX-5133, covering 2017-07-21 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment [Phase 1]